A kind of production method of penconazole

Through the two-step process of bromination reaction and condensation reaction, combined with cooling and crystallization purification, the problems of poor stability and safety hazards of phenanthazole synthesis process are solved, the yield and purity are improved, and the safety and environmental protection of synthesis are ensured.

CN115626899BActive Publication Date: 2024-11-19JIANGSU HEBEN BIOCHEM
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211570653.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-12-08
Publication Date
2024-11-19
Estimated Expiration
2042-12-08

AI Technical Summary

Technical Problem

The existing phenanthrosazole synthesis process has poor stability and low yield. The use of highly toxic substances and dangerous feeding methods increases the risk of safety accidents, and there are safety hazards of environmental pollution and fire explosions.

Method used

Using a two-step synthesis process of bromination and condensation reaction, 2-(2,4-dichlorophenyl)pentanol and hydrobromic acid are used for bromination, followed by 1,2,4-triazole sodium salt, Potassium carbonate and DMF are condensed and refined by cooling and crystallization to obtain the finished product of verazole, avoiding the safety risks of esterification reaction and acid-base neutralization.

Benefits of technology

It improves the stability, yield and purity of verazole, reduces the risk of safety accidents, reduces the generation of three wastes, and ensures the safety and environmental protection of synthesis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115626899B_ABST
    Figure CN115626899B_ABST
Patent Text Reader

Abstract

The invention discloses a technical field of synthesis of original drugs, and discloses a production method of penconazole, comprising two steps: 1) using 2-(2,4-dichlorophenyl)pentanol as a reaction starting material to obtain a bromide through a bromination reaction; 2) the bromide is first subjected to a condensation reaction, and then refined to achieve the preparation of a finished penconazole product. The invention changes the original synthesis route of penconazole, thereby improving the stability, yield and purity of the penconazole synthesis process, and does not need to use a more dangerous feeding method to feed auxiliary materials, thereby avoiding safety accidents caused by feeding auxiliary materials, improving the safety of the use of raw and auxiliary materials, making the synthesis of penconazole safer and more reliable, avoiding safety accidents caused by fire and explosion due to static electricity or acid-base neutralization, improving the safety factor of penconazole synthesis, reducing the generation of three wastes, inhibiting the generation of highly toxic three wastes, and ensuring the safety of penconazole synthesis.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of synthesis of original drugs, and specifically relates to a production method of penconazole. Background Art

[0002] Penconazole, English name Penconazole, molecular formula is C 13 H 15 Cl 2 N 3 , molecular weight is 284.18, CAS registration number is 66246-88-6, it is a gray solid, used to control powdery mildew, black star fungus and other diseases of spore fungi, aspergillus and imperfect fungi.

[0003] At present, there are many synthetic processes for penconazole. For example, Chinese patent CN102584726A discloses a method for preparing the fungicide penconazole, which proposes "using 2,4-dichlorophenylbutyric acid, sodium methoxide, methyl chloroacetate, methylsulfonyl chloride and 1,2,4-triazole as main raw materials, and adopting a four-step reaction synthesis route of Darson condensation, potassium borohydride reduction, esterification and synthesis to prepare penconazole". The routes of the esterification reaction and the synthesis reaction are as follows:

[0004] Esterification reaction:

[0005] ,

[0006] Synthesis reaction:

[0007] ,

[0008] The esterification reaction in this method uses liquid highly toxic substance methylsulfonyl chloride (CH3SO2Cl), which has certain volatility and is very harmful to operators. There are many safety hazards when using it. In addition, excessive methylsulfonyl chloride is added during the reaction. If the methylsulfonyl chloride is not properly disposed of, highly toxic waste will be produced, which will not only increase the probability of safety accidents, but also cause environmental pollution.

[0009] For example, Chinese patent CN110016000A discloses a penconazole technical and a preparation method thereof, which states that "2,4-dichlorobutyrophenone, dimethyl sulfoxide, toluene, dimethyl sulfate, sodium hydroxide, tetrabutylammonium bromide, tetrahydrofuran, zinc powder, potassium carbonate, 1,2,4-triazole, methylsulfonyl chloride, triethylamine, methanol, sodium methoxide, and cyclohexane are used as main raw and auxiliary materials, and a crude penconazole product is synthesized in four steps." The synthesis route of this preparation method is similar to the synthesis route of a preparation method of a fungicide penconazole disclosed in the above-mentioned Chinese patent CN102584726A. Both methods use the highly toxic substance methylsulfonyl chloride to complete the esterification reaction, which increases the probability of safety accidents and causes certain environmental pollution.

[0010] At present, concentrated sulfuric acid has been used to replace the highly toxic substance methanesulfonyl chloride to complete the esterification reaction. For example, Chinese patent CN114315743A discloses "a new method for synthesizing penconazole", which proposes "using 2-(2,4-dichlorophenyl)pentanol and concentrated sulfuric acid as reaction raw materials, 4-methyl-2-pentanone as a water-carrying agent, first synthesizing sulfate ester, and then synthesizing penconazole with 1,2,4-triazole under alkaline conditions to synthesize penconazole", and its synthesis reaction equation is as follows:

[0011] ,

[0012] This prior art uses the intermediate 2-(2,4-dichlorophenyl)pentanol, which is consistent with the public reports of Chinese patents CN102584726A and CN110016000A, as the starting material, and obtains penconazole through esterification. The esterification reaction uses concentrated sulfuric acid for esterification. Although it avoids the environmental problems caused by the use of highly toxic methylsulfonyl chloride, the 4-methyl-2-pentanone (boiling point is 115.9°C) of the prior art is dehydrated with concentrated sulfuric acid under reflux conditions, and concentrated sulfuric acid is more likely to carbonize and dehydrate organic matter under high temperature and anhydrous conditions. Water generates olefins and ether impurities, which pose safety risks and reduce the yield of the product, thereby increasing the cost of the product. When the generated esterification product is cooled to room temperature, a large amount of solid sodium hydroxide will be added. Since the solid sodium hydroxide is added through the manhole on the reactor, static electricity will inevitably be generated when the manhole is opened, thereby igniting and detonating the water-containing agent in the reactor, which poses a safety risk. In addition, the esterification product generated by this prior art is still acidic, and a large amount of strong alkali needs to be added for neutralization. During neutralization, the local temperature will rise sharply, resulting in serious safety problems such as fire and explosion caused by the impact of materials. Therefore, a new technical solution is needed to solve the above technical problems. Summary of the invention

[0013] The object of the present invention is to provide a production method of penconazole, so as to solve the problems that the current synthesis process of penconazole proposed in the above background technology has poor stability, low yield, low safety of raw and auxiliary materials, and the use of a more dangerous feeding method increases the probability of safety accidents and has a low safety factor.

[0014] To achieve the above object, the present invention provides the following technical solution: a method for producing penconazole, the specific synthesis route is as follows:

[0015] ;

[0016] Among them, 2-(2,4-dichlorophenyl)pentanol is used as the starting material for the reaction to obtain bromide through bromination reaction, and the bromide is first subjected to condensation reaction and then refined to achieve the preparation of penconazole finished product.

[0017] The specific synthesis steps of penconazole produced according to the above synthesis route are as follows:

[0018] S1. Preparation of bromide: Add 2-(2,4-dichlorophenyl)pentanol and hydrobromic acid into reactor I and carry out bromination reaction at 100-125°C for 5-6 hours, cool to 40-50°C and stand for stratification, the lower layer material is bromide, wherein the molar ratio of 2-(2,4-dichlorophenyl)pentanol to hydrobromic acid is 1:2-2.5;

[0019] S2. Preparation of finished penconazole product: 1,2,4-triazole sodium salt, potassium carbonate, and DMF are added to reactor II, and the bromide in the lower layer of reactor I is added dropwise at 120-130°C within 2-3 hours to carry out condensation reaction. After the reaction, reactor II is heated to 145-150°C under a vacuum of 0-0.095MPa until no more liquid is produced, and then emptied under nitrogen, and toluene and water are added to reactor II, and stirred at 40-50°C for 1-2 hours, allowed to stand, the lower water layer is separated, and toluene is removed, and then methylcyclohexane is added at 70-80°C, the temperature is raised to reflux, the temperature is lowered to 20-25°C for crystallization for 2-4 hours, and the temperature is then lowered to 0- The product is crystallized at 5°C for 2 to 4 hours, discharged by centrifugation, and dried to obtain a penconazole product, wherein the molar ratio of 1,2,4-triazole sodium salt to 2-(2,4-dichlorophenyl)pentanol is 1.05 to 1.1:1, the weight ratio of potassium carbonate to 2-(2,4-dichlorophenyl)pentanol is 0.05 to 0.1:1, the weight ratio of DMF to 2-(2,4-dichlorophenyl)pentanol is 2 to 3:1, the weight ratio of toluene to 2-(2,4-dichlorophenyl)pentanol is 2 to 3:1, the weight ratio of water to 2-(2,4-dichlorophenyl)pentanol is 0.4 to 0.6:1, and the weight ratio of methylcyclohexane to 2-(2,4-dichlorophenyl)pentanol is 1.8 to 2.2:1.

[0020] Compared with the prior art, the present invention has the following beneficial effects:

[0021] 1. The invention adopts a two-step synthesis process of bromination reaction-condensation reaction to produce a penconazole finished product, so that the original synthesis route of penconazole is changed, thereby effectively improving the stability, yield and purity of the penconazole synthesis process, and adopts raw and auxiliary materials without highly toxic substances and easily available, so that the synthesis of penconazole is more stable and fast, and there is no need to adopt a more dangerous feeding method to feed auxiliary materials, which effectively avoids safety accidents caused by feeding auxiliary materials, effectively improves the use safety of raw and auxiliary materials, prepares penconazole by a refined method, makes the synthesis of penconazole safer and more reliable, effectively avoids safety accidents caused by fire and explosion due to static electricity or acid-base neutralization, effectively improves the safety factor of penconazole synthesis, and also effectively reduces the generation of three wastes, inhibits the generation of highly toxic three wastes, and ensures the safety of penconazole synthesis.

[0022] 2. The present invention utilizes 2-(2,4-dichlorophenyl)pentanol and hydrobromic acid for bromination reaction, so that the original synthesis route of penconazole is changed, and penconazole is no longer synthesized through esterification reaction, thereby effectively improving the stability, yield and purity of the penconazole synthesis process, and then utilizing bromide and 1,2,4-triazole sodium salt, potassium carbonate and DMF for condensation reaction, so that the synthesis of penconazole is more stable and faster, and there is no need to use a more dangerous feeding method to feed auxiliary materials, which effectively avoids safety accidents caused by feeding auxiliary materials, and effectively improves the safety of penconazole production.

[0023] 3. The present invention adopts a cooling crystallization refining method to produce penconazole, which makes the synthesis of penconazole safer and more reliable, effectively avoids safety accidents caused by static electricity or acid-base neutralization and fire and explosion, effectively improves the safety factor of penconazole synthesis, and carries out bromination reaction and condensation reaction respectively by reactor I and reactor II, effectively reduces the generation of three wastes, inhibits the generation of highly toxic three wastes, and ensures the safety of penconazole synthesis. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 is a chromatogram of the penconazole standard product of the present invention;

[0025] Figure 2 is a chromatogram of the refined product of penconazole of the present invention;

[0026] Figure 3 The chromatogram is a chromatogram of the penconazole reference substance and the refined product of the present invention. DETAILED DESCRIPTION

[0027] The following examples are used to further illustrate the content of the present invention, but do not limit the application of the present invention.

[0028] Embodiment 1:

[0029] Step 1, preparation of bromide:

[0030] Put 932kg of 2-(2,4-dichlorophenyl)pentanol and 1296kg of 50% hydrobromic acid into a clean (3000L) reactor I, raise the temperature to 100-125℃ and reflux for 5-6 hours of bromination reaction, take samples after the reaction is completed, and control 2-(2,4-dichlorophenyl)pentanol ≤0.5%. After the sampling is qualified, cool it to 40-50℃ and let it stand for stratification. The lower layer material is the bromide;

[0031] Step 2, preparation of penconazole finished product:

[0032] In a dry and clean (5000L) reactor II, 382.2kg of 1,2,4-triazole sodium salt, 46.6kg of potassium carbonate and 1864kg of DMF (N,N-dimethylformamide) were added in sequence. The temperature was raised to 120-130°C, and the bromide in the lower layer of reactor I was added dropwise within 2-3 hours. After the addition was completed, the temperature was kept warm for 8-10 hours for condensation reaction. After the reaction was completed, samples were taken, and the bromide content was controlled to be ≤1%. After the sampling was qualified, the temperature was lowered to 80-85°C, and the vacuum was slowly opened and the slip rate was controlled (the slip rate should not be too fast) until the vacuum pressure reached -0.095MPa. The reactor II was slowly heated until the temperature in the reactor II reached 145 The reaction kettle was heated to 150°C (i.e., no sluicing), and kept at this temperature for 1 to 2 hours after no sluicing occurred, and then the temperature was further lowered to 70 to 80°C, and the mixture was emptied under nitrogen. Then, 1864 kg of toluene and 372.8 kg of water were added to the reaction kettle II, and the mixture was stirred at 40 to 50°C for 1 to 2 hours, and the mixture was allowed to stand and the lower water layer was separated to remove the toluene. Then, 1677.6 kg of methylcyclohexane was added to the reaction kettle II at 70 to 80°C, and the mixture was heated to reflux for 1 hour, and then the mixture was cooled to 20 to 25°C and crystallized for 3 hours, and then the mixture was cooled to 0 to 5°C and crystallized for 3 hours. The mixture was discharged and centrifuged, and dried to obtain 1134.85 kg of penconazole finished product, with a content of 98.6% and a yield of 98.5%.

[0033] Embodiment 2:

[0034] Step 1, preparation of bromide:

[0035] Put 932kg of 2-(2,4-dichlorophenyl)pentanol and 1620kg of 50% hydrobromic acid into a clean (3000L) reactor I, raise the temperature to 100-125℃ and reflux for 5-6 hours of bromination reaction, take samples after the reaction is completed, and control 2-(2,4-dichlorophenyl)pentanol ≤0.5%. After the sampling is qualified, cool it to 40-50℃ and let it stand for stratification. The lower layer material is the bromide;

[0036] Step 2, preparation of penconazole finished product:

[0037] Into a dry and clean (5000L) reactor II, 400.4kg of 1,2,4-triazole sodium salt, 93.2kg of potassium carbonate and 2796kg of DMF were added in sequence, the temperature was raised to 120-130°C, and the bromide in the lower layer of reactor I was added dropwise within 2-3 hours. After the addition was completed, the temperature was kept warm for 8-10 hours for condensation reaction. After the reaction was completed, sampling was performed, and the bromide content was controlled to be ≤1%. After the sampling was qualified, the temperature was lowered to 80-85°C, the vacuum was slowly opened, and the slip rate was controlled (the slip rate should not be too fast) until the vacuum pressure reached -0.095MPa, and the reactor II was slowly heated until the temperature in the reactor II reached 145-150°C (i.e. After no slip occurs, keep the temperature for 1 to 2 hours, then cool the temperature to 70 to 80°C, vent under nitrogen, add 2796 kg of toluene and 559.2 kg of water into the reactor II, stir at 40 to 50°C for 1 to 2 hours, let stand and separate the lower water layer, remove the toluene, and then add 2050.4 kg of methylcyclohexane into the reactor II at 70 to 80°C, heat and reflux for 1 hour, then cool to 20 to 25°C and keep warm for crystallization for 3 hours, continue to cool to 0 to 5°C and keep warm for crystallization for 3 hours, discharge the material, centrifuge, and dry to obtain 1144.10 kg of penconazole finished product with a content of 98.2% and a yield of 98.9%.

[0038] Embodiment 3:

[0039] Step 1, preparation of bromide:

[0040] Put 932kg of 2-(2,4-dichlorophenyl)pentanol and 1521kg of 50% hydrobromic acid into a clean (3000L) reactor I, raise the temperature to 100-125℃ and reflux for 5-6 hours of bromination reaction, take samples after the reaction is completed, and control 2-(2,4-dichlorophenyl)pentanol ≤0.5%. After the sampling is qualified, cool it to 40-50℃ and let it stand for stratification. The lower layer material is the bromide;

[0041] Step 2, preparation of penconazole finished product:

[0042] Into a dry and clean (5000L) reactor II, 392.1kg of 1,2,4-triazole sodium salt, 86.2kg of potassium carbonate and 2563kg of DMF were added in sequence. The temperature was raised to 120-130°C, and the bromide in the lower layer of reactor I was added dropwise within 2-3 hours. After the addition was completed, the condensation reaction was carried out for 8-10 hours at a temperature of 0.1°C. After the reaction was completed, samples were taken, and the bromide content was controlled to be ≤1%. After the samples were qualified, the temperature was lowered to 80-85°C, and the vacuum was slowly opened and the slip rate was controlled (the slip rate should not be too fast) until the vacuum pressure reached -0.095MPa, and then the reactor II was slowly heated until the temperature inside the reactor II reached 145-150°C. (i.e. no slip), keep it for 1 to 2 hours after it stops slipping, then cool it to 70 to 80°C, vent it under nitrogen, add 2563 kg of toluene and 406 kg of water to the reactor II, stir it at 40 to 50°C for 1 to 2 hours, let it stand and separate the lower water layer, remove the toluene, and then add 1873 kg of methylcyclohexane to the reactor II at 70 to 80°C, heat and reflux for 1 hour, then cool it to 20 to 25°C and keep it warm for crystallization for 3 hours, continue to cool it to 0 to 5°C and keep it warm for crystallization for 3 hours, discharge the material, centrifuge it, and dry it to obtain 1131.39 kg of penconazole finished product, with a content of 98.6% and a yield of 98.2%.

[0043] Embodiment 4:

[0044] Step 1, preparation of bromide:

[0045] Put 932kg of 2-(2,4-dichlorophenyl)pentanol and 1600kg of 50% hydrobromic acid into a clean (3000L) reactor I, raise the temperature to 100-125℃ and reflux for 5-6 hours of bromination reaction, take samples after the reaction is completed, and control 2-(2,4-dichlorophenyl)pentanol ≤0.5%. After the sampling is qualified, cool it to 40-50℃ and let it stand for stratification. The lower layer material is the bromide;

[0046] Step 2, preparation of penconazole finished product:

[0047] Into a dry and clean (5000L) reactor II, 398kg of 1,2,4-triazole sodium salt, 88.9kg of potassium carbonate and 2600kg of DMF were added in sequence, the temperature was raised to 120-130°C, and the bromide in the lower layer of reactor I was added dropwise within 2-3 hours. After the addition was completed, the temperature was kept warm for 8-10 hours for condensation reaction. After the reaction was completed, sampling was performed, and the bromide content was controlled to be ≤1%. After the sampling was qualified, the temperature was lowered to 80-85°C, the vacuum was slowly opened, and the slip rate was controlled (the slip rate should not be too fast) until the vacuum pressure reached -0.095MPa, and the reactor II was slowly heated until the temperature in the reactor II reached 145-150°C (i.e. The reaction kettle II was stirred for 1 to 2 hours at 40 to 50°C, and the mixture was allowed to stand for 1 to 2 hours under nitrogen atmosphere. The mixture was then refluxed for 1 hour, and the temperature was kept at 20 to 25°C for crystallization for 3 hours. The mixture was further cooled to 0 to 5°C for crystallization for 3 hours. The mixture was centrifuged and dried to obtain 1133.69 kg of penconazole finished product with a content of 98.5% and a yield of 98.3%.

[0048] The method for confirming the finished product of penconazole is to use the penconazole standard as the reference substance to confirm that the refined penconazole product is the finished product of penconazole. Figure 1-Figure 3 As shown, the following is a table of analysis results related to penconazole:

[0049] The chromatogram of the standard penconazole is as follows Figure 1 The analysis results are shown in the table below:

[0050] ;

[0051] The chromatogram of the refined product of penconazole is as follows Figure 2 The analysis results are shown in the table below:

[0052] ;

[0053] The chromatogram of the penconazole reference substance plus the refined product is as follows Figure 3 The analysis results are shown in the table below:

[0054]

Claims

1. A method for producing penconazole, It is characterized in that The specific synthetic route is as follows: ; Among them, 2-(2,4-dichlorophenyl)pentanol is used as the starting material for the reaction, and a bromide is obtained through a bromination reaction. The bromide is first subjected to a condensation reaction, and then refined to achieve the preparation of the finished product of penconazole; The specific synthesis steps of the penconazole finished product are as follows: S1. Preparation of bromide: Add 2-(2,4-dichlorophenyl)pentanol and hydrobromic acid into reactor I and carry out bromination reaction at 100-125°C for 5-6 hours, cool to 40-50°C, stand for stratification, and the lower layer material is bromide, wherein the molar ratio of 2-(2,4-dichlorophenyl)pentanol to hydrobromic acid is 1:2-2.5; S2. Preparation of finished penconazole product: 1,2,4-triazole sodium salt, potassium carbonate, and DMF are added to reactor II, and the bromide in the lower layer of reactor I is added dropwise at 120-130° C. within 2-3 hours to carry out condensation reaction. After the reaction, reactor II is heated under vacuum until no liquid is produced, and then emptied under nitrogen. Toluene and water are added to reactor II with stirring, and the mixture is allowed to stand and the lower water layer is separated to remove the toluene. Methylcyclohexane is then added at 70-80° C., the mixture is heated to reflux, cooled to crystallize, discharged by centrifugation, and dried to obtain finished penconazole product, wherein the cooling crystallization is performed twice, the temperature of the first cooling crystallization is 20-25° C., the time of the first cooling crystallization is 2-4 hours, the temperature of the second cooling crystallization is 0-5° C., and the time of the second cooling crystallization is 2-4 hours.

2. The method for producing penconazole according to claim 1, It is characterized in that In S2, the molar ratio of 1,2,4-triazole sodium salt to 2-(2,4-dichlorophenyl)pentanol is 1.05-1.1:

1.

3. The method for producing penconazole according to claim 1, It is characterized in that In S2, the weight ratio of potassium carbonate to 2-(2,4-dichlorophenyl)pentanol is 0.05 to 0.1:1, and the weight ratio of DMF to 2-(2,4-dichlorophenyl)pentanol is 2 to 3:

1.

4. The method for producing penconazole according to claim 1, It is characterized in that In S2, the weight ratio of toluene to 2-(2,4-dichlorophenyl)pentanol is 2 to 3:1, and the weight ratio of water to 2-(2,4-dichlorophenyl)pentanol is 0.4 to 0.6:

1.

5. The method for producing penconazole according to claim 1, It is characterized in that In S2, the weight ratio of methylcyclohexane to 2-(2,4-dichlorophenyl)pentanol is 1.8 to 2.2:

1.

6. The method for producing penconazole according to claim 1, It is characterized in that In S2, the vacuum pressure is 0 to -0.095 MPa, the heating temperature is 145 to 150°C, the stirring temperature is 40 to 50°C, and the stirring time is 1 to 2 hours.